CD4 and COVID-19: Recent studies carried out in Australia, Germany, Sweden, the United Kingdom, and the United States have reported a particularly high frequency of S-specific CD4+ T cell responses among COVID-19 early convalescent patients approximately 1 month PSO7,21,23,24,33–35.